Treatment of status epilepticus

References

• Commission on epidemiology and prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia34, 592–596 (1993).
   PubMed Web of Science ®Google Scholar
• Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia40, 120–122 (1999).
   PubMed Web of Science ®Google Scholar
• Hauser WA. Status epilepticus: epidemiologic considerations. Neurology40(5 Suppl. 2), 9–13 (1990).
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Hauser WA, Towne AR et al. A prospective population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology46, 1029–1035 (1996).
   PubMed Web of Science ®Google Scholar
• Barry E, Hauser WA. Status epilepticus: the interaction of epilepsy and acute brain disease. Neurology43, 1473–1478 (1993).
   PubMed Web of Science ®Google Scholar
• Devinsky O, Kelley K, Porter RJ, Theodore WH. Clinical and electroencephalographic features of simple partial seizures. Neurology38, 1347–1352 (1998).
   Google Scholar
• Kaplan PW. Clinical presentations of nonconvulsive status epilepticus. In: Status Epilepticus – a Clinical Perspective. Drislane FW (Ed.). Humana Press, NJ, USA (2005).
   Google Scholar
• Devinsky O, Thacker K. Nonepileptic seizures. Neurologic Clinics13, 299–319 (1995).
   PubMed Web of Science ®Google Scholar
• Krumholz A. Nonepileptic seizures: diagnosis and management. Neurology53(Suppl. 2), 76–83 (1999).
   Google Scholar
• Dworetzky BA, Bromfield EB. Differential diagnosis of status epilepticus. In: Status Epilepticus – a Clinical Perspective. Drislane FW (Ed.). Humana Press, NJ, USA (2005).
   Google Scholar
• Howell SJL, Owen L, Chadwick DW. Pseudostatus epilepticus. Q. J. Med.71, 507–519 (1989).
   PubMedGoogle Scholar
• Aminoff MF, Simon RP. Status epilepticus: causes, clinical features, and consequences in 98 patients. Am. J. Med.69, 657–666 (1980).
   PubMed Web of Science ®Google Scholar
• Shorvon SS. Prognosis and outcome of status epilepticus. In: Status Epilepticus: its Clinical Features and Treatment in Children and Adults. Shorvon S (Ed.). Cambridge University Press, Cambridge, UK (1994).
   Google Scholar
• Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia35, 27–34 (1994).
   PubMed Web of Science ®Google Scholar
• Schomer DL. Focal status epilepticus and epilepsia partialis continua in adults and children. Epilepsia34(Suppl. 1), S29–S36 (1993).
   PubMed Web of Science ®Google Scholar
• Simon R, Pellock JM, DeLorenzo RJ. Acute morbidity and mortality of status epilepticus. In: Epilepsy: a Comprehensive Textbook. Engel J, Pedley TA (Eds). Lippincott-Raven Publishers, PA, USA (1997).
   Google Scholar
• Drislane FW, Blum AS, Schomer DL. Focal status epilepticus: clinical features and significance of different EEG patterns. Epilepsia40, 1254–1260 (1999).
   PubMed Web of Science ®Google Scholar
• Belafsky MA, Carwille S, Miller P, Waddell G, Boxley-Johnson J, Delgado-Escueta AV. Prolonged epileptic twilight states: continuous recordings with nasopharyngeal electrodes and videotape analysis. Neurology28, 239–245 (1978).
   PubMed Web of Science ®Google Scholar
• Engel J, Ludwig BI, Fetell M. Prolonged partial complex status epilepticus: EEG and behavioral observations. Neurology28, 863–869 (1978).
   PubMed Web of Science ®Google Scholar
• Treiman DM, Delgado-Escueta AV. Complex partial status epilepticus. In: Status Epilepticus. (Advances in Neurology; Vol. 34). Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (Eds). Raven Press, NY, USA (1983).
   Google Scholar
• Cockerell OC, Walker MC, Sander JWAS, Shorvon SD. Complex partial status epilepticus: a recurrent problem. J. Neurol. Neurosurg. Psychiatry57, 835–837 (1994).
   PubMedGoogle Scholar
• Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol.6, 329–339 (2007).
   PubMed Web of Science ®Google Scholar
• Shorvon S, Walker M. Status epilepticus in idiopathic generalized epilepsy. Epilepsia46(Suppl. 9), 73–79 (2005).
   PubMed Web of Science ®Google Scholar
• Thomas P, Beaumanoir A, Genton P, Dolisi C, Chatel M. ‘De novo’ absence status of late onset: report of 11 cases. Neurology42, 104–110 (1992).
   PubMed Web of Science ®Google Scholar
• Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology61, 1066–1073 (2003).
   PubMed Web of Science ®Google Scholar
• Tomson T, Lindbom U, Nilsson BY. Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population. Epilepsia33, 829–835 (1992).
   PubMed Web of Science ®Google Scholar
• Kaplan PW. Nonconvulsive status epilepticus. Semin. Neurol.16, 33–40 (1996).
   PubMed Web of Science ®Google Scholar
• Treiman DM, Walton NY, Kendrick C. A progressive sequence of electrographic changes during generalized convulsive status epilepticus. Epilepsy Res.5, 49–60 (1990).
   PubMed Web of Science ®Google Scholar
• Drislane FW, Schomer DL. Clinical implications of generalized electrographic status epilepticus. Epilepsy Res.19, 111–121 (1994).
   PubMedGoogle Scholar
• Treiman DM, Meyers PD, Walton NY et al. A comparison of four treatments for generalized convulsive status epilepticus. N. Engl. J. Med.339, 792–798 (1998).
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Waterhouse EJ, Towne AR et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia39, 833–840 (1998).
   PubMed Web of Science ®Google Scholar
• Towne AR, Waterhouse EJ, Boggs JG et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology54, 340–345 (2000).
   PubMed Web of Science ®Google Scholar
• Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology62, 1743–1748 (2004).
   PubMed Web of Science ®Google Scholar
• So EL, Ruggles KH, Ahmann PA, Trudeau SK, Weatherford KJ, Trenerry MR. Clinical significance and outcome of subclinical status epilepticus in adults. J. Epilepsy8, 11–15 (1995).
   Google Scholar
• Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann. Emerg. Med.22, 1337–1348 (1993).
   PubMed Web of Science ®Google Scholar
• Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia42, 380–386 (2001).
   PubMed Web of Science ®Google Scholar
• Towne AR, Garnett LK, Waterhouse RJ, Morton LD, DeLorenzo RJ. The use of topiramate in refractory status epilepticus. Neurology60, 332–334 (2003).
   PubMed Web of Science ®Google Scholar
• Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch. Neurol.59, 205–210 (2002).
   PubMed Web of Science ®Google Scholar
• Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J. Neurol. Neurosurg. Psychiatry76, 534–539 (2005).
   PubMed Web of Science ®Google Scholar
• Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia37, 863–867 (1996).
   PubMedGoogle Scholar
• Osorio I, Reed RC. Treatment of refractory generalized tonic–clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia30, 464–471 (1989).
   PubMed Web of Science ®Google Scholar
• Yaffe K, Lowenstein DH. Prognostic factors for pentobarbital therapy for refractory generalized status epilepticus. Neurology43, 895–900 (1993).
   PubMed Web of Science ®Google Scholar
• Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology38, 1035–1040 (1988).
   PubMed Web of Science ®Google Scholar
• Limdi NA, Knowlton RK, Cofield SS, Ver Hoef LW, Paige AL, Dutta S, Faught E. Safety of rapid intravenous loading of valproate. Epilepsia48, 478–483 (2007).
   PubMed Web of Science ®Google Scholar
• Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology55, 722–724 (2000).
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology67, 340–342 (2006).
   PubMed Web of Science ®Google Scholar
• Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure16, 527–532 (2007).
   PubMed Web of Science ®Google Scholar
• Olsen KB, Tauboll E, Gjerstad L. Valproate is an effective, well-tolerated drug for the treatment of status epilepticus/serial attacks in adults. Acta Neurol. Scand. Suppl.187, 51–54 (2007).
   PubMedGoogle Scholar
• Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav.8, 651–654 (2006).
   PubMed Web of Science ®Google Scholar
• Ramael S, Daoust A, Otoul C et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia47, 1128–1135 (2006).
   PubMed Web of Science ®Google Scholar
• Rüegg S, Naegelin Y, Hardmeier M, Winkler DT, Marsch S, Fuhr P. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav.12, 477–480 (2008).
   PubMed Web of Science ®Google Scholar
• Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res.73, 238–244 (2007).
   PubMed Web of Science ®Google Scholar
• Farooq MU, Naravetia B, Majid A, Gupta R, Pysh JJ, Kassab MY. IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit. Care7, 36–39 (2007).
   PubMed Web of Science ®Google Scholar
• Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology43, 483–488 (1993).
   PubMed Web of Science ®Google Scholar
• Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res.814, 179–185 (1998).
   PubMed Web of Science ®Google Scholar
• Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J. Neurosci.17, 7532–7540 (1997).
   PubMed Web of Science ®Google Scholar
• Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J. Clin. Neurophysiol.12, 326–342 (1995).
   PubMedGoogle Scholar
• Chen JWY, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol.5, 246–256 (2006).
   PubMed Web of Science ®Google Scholar
• Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia40(Suppl. 1), S59–S63 (1999).
   Web of Science ®Google Scholar
• Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit. Care Med.20, 483–488 (1992).
   PubMed Web of Science ®Google Scholar
• Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology44, 1837–1840 (1994).
   PubMed Web of Science ®Google Scholar
• Ulvi H, Yoldas T, Mungen B, Yigiter R. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus. Neurol. Sci.23, 177–182 (2002).
   PubMedGoogle Scholar
• Lowenstein DH, Alldredge BK. Status epilepticus. N. Engl. J. Med.338, 970–976 (1998).
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Reichart MD, Schaller M, Despland P, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia45, 757–763 (2004).
   PubMed Web of Science ®Google Scholar
• Rasmussen PA, Yang Y, Ruteki PA. Propofol inhibits epileptiform activity in rat hippocampal slices. Epilepsy Res.25, 169–175 (1996).
   PubMedGoogle Scholar
• Stecker MM, Kramer TH, Raps EC, O’Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia39, 18–26 (1998).
   PubMed Web of Science ®Google Scholar
• Parke TJ, Stevens JE, Rice AS et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ305, 613–616 (1992).
   PubMed Web of Science ®Google Scholar
• Cremer OL, Moons KG, Bouman EAC, Kruijswijk JE, de Smet AMGA, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet357, 117–118 (2001).
   PubMed Web of Science ®Google Scholar
• Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med.29, 1417–1425 (2003).
   PubMed Web of Science ®Google Scholar
• Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systemic review. Epilepsia43, 146–153 (2002).
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch. Neurol.62, 1698–1702 (2005).
   PubMedGoogle Scholar
• Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia40, 759–762 (1999).
   PubMed Web of Science ®Google Scholar
• Walker MC, Howard RS, Smith SJ, Miller DH, Shorvon SD, Hirsch NP. Diagnosis and treatment of status epilepticus on a neurological intensive care unit. Q. J. Med.89, 913–920 (1996).
   Google Scholar
• Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology57, 1036–1042 (2001).
   PubMed Web of Science ®Google Scholar
• Sheth RD, Gidal BE. Refractory status epilepticus: response to ketamine. Neurology51, 1765–1766 (1998).
   PubMedGoogle Scholar
• Mazarati AM, Wasterlain CG. N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci. Lett.265, 187–190 (1999).
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Sombati S, Coulter DA. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia41(Suppl. 1), 40–44 (2000).
   PubMed Web of Science ®Google Scholar
• Petroff OA, Hyder F, Rothman DL, Mattson RH. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia42, 543–548 (2001).
   PubMed Web of Science ®Google Scholar
• White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia41(Suppl. 1), 17–20 (2000).
   PubMed Web of Science ®Google Scholar
• Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of topiramate: blockage of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia31(Suppl. 1), 10–16 (2000).
   Google Scholar
• Alexopoulos A, Lachhwani DK, Gupta A et al. Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis. Neurology64, 567–570 (2005).
   PubMed Web of Science ®Google Scholar
• Ma X, Liporace J, O’Connor MJ, Sperling MR. Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res.46, 33–38 (2001).
   PubMed Web of Science ®Google Scholar
• Ng YT, Bristol RE, Schrader DV, Smith KA. The role of neurosurgery in status epilepticus. Neurocrit. Care7, 86–91 (2007).
   PubMedGoogle Scholar
• Duane DC, Ng Y, Rekate HL, Chung S, Bodensteiner JB, Kerrigan JF. Treatment of refractory status epilepticus with hemispherectomy. Epilepsia45, 1001–1004 (2004).
   PubMedGoogle Scholar
• Piatt JH, Hwang PA, Armstrong DC, Becker LE, Hoffman HJ. Chronic focal encephalitis (Rasmussen syndrome): six cases. Epilepsia29, 268–279 (1998).
   Google Scholar
• Drislane FW. Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J. Clin. Neurophysiol.16, 323–331 (1999).
   PubMedGoogle Scholar
• Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch. Neurol.61, 1254–1259 (2004).
   PubMedGoogle Scholar
• Kaplan PW. Assessing the outcome in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J. Clin. Neurophysiol.16, 341–352 (1999).
   PubMed Web of Science ®Google Scholar
• Kaplan PW. Prognosis in nonconvulsive status epilepticus. Epileptic Disord.2, 185–193 (2000).
   PubMedGoogle Scholar
• Aganthonikou A, Panayiotopoulos CP, Giannakodimos S, Koutroumanidis M. Typical absence status in adults: diagnostic and syndromic considerations. Epilepsia39, 1265–1276 (1998).
   PubMedGoogle Scholar
• Guberman A, Cantu-Reyna G, Stuss D, Broughton R. Nonconvulsive generalized status epilepticus: clinical features, neuropsychological testing, and long-term follow-up. Neurology36, 1284–1291 (1986).
   PubMed Web of Science ®Google Scholar
• Kaplan PW. Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin. Electroencephalogr.30, 1–4 (1999).
   PubMedGoogle Scholar
• Osorio I, Reed RC, Peltzer JN. Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia41, 887–894 (2000).
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP, Agathonikou A, Sharoqi IA, Parker AP. Vigabatrin aggravates absences and absence status. Neurology49, 1467 (1997).
   PubMed Web of Science ®Google Scholar
• Ettinger AB, Bernal OG, Andriola MR et al. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia40, 1159–1162 (1999).
   PubMed Web of Science ®Google Scholar
• Shorvon S. The management of status epilepticus. J. Neurol. Neurosurg. Psychiatry70(Suppl. 2), II22–II27 (2001).
   PubMedGoogle Scholar
• Williamson PD. Complex partial status epilepticus. In: Epilepsy: a Comprehensive Textbook. Engel J, Pedley TA (Eds). Lippincott-Raven Publishers, PA, USA (1997).
   Google Scholar
• Fagan KJ, Lee SI. Prolonged confusion following convulsions due to generalized nonconvulsive status epilepticus. Neurology40, 1689–1694 (1990).
   PubMed Web of Science ®Google Scholar
• Drislane FW, Schomer DL. Anticonvulsant medication use in patients with continuous epileptiform discharges. Clin. Neuropharmacol.17, 165–174 (1994).
   Google Scholar
• Thomas P, Zifkin B, Migneco O, Lebrun C, Darcourt J, Andermann F. Nonconvulsive status epilepticus of frontal origin. Neurology52, 1174–1183 (1999).
   PubMed Web of Science ®Google Scholar
• Kaplan PW. Nonconvulsive status epilepticus in the emergency room. Epilepsia37, 643–650 (1996).
   PubMed Web of Science ®Google Scholar